445 related articles for article (PubMed ID: 21541975)
1. Disparities at presentation, diagnosis, treatment, and survival in African American men, affected by prostate cancer.
Chornokur G; Dalton K; Borysova ME; Kumar NB
Prostate; 2011 Jun; 71(9):985-97. PubMed ID: 21541975
[TBL] [Abstract][Full Text] [Related]
2. Racial and Ethnic Disparities in Prostate Cancer Outcomes in the Veterans Affairs Health Care System.
Yamoah K; Lee KM; Awasthi S; Alba PR; Perez C; Anglin-Foote TR; Robison B; Gao A; DuVall SL; Katsoulakis E; Wong YN; Markt SC; Rose BS; Burri R; Wang C; Aboiralor O; Fink AK; Nickols NG; Lynch JA; Garraway IP
JAMA Netw Open; 2022 Jan; 5(1):e2144027. PubMed ID: 35040965
[TBL] [Abstract][Full Text] [Related]
3. Racial disparity in prostate cancer in the African American population with actionable ideas and novel immunotherapies.
Dovey ZS; Nair SS; Chakravarty D; Tewari AK
Cancer Rep (Hoboken); 2021 Oct; 4(5):e1340. PubMed ID: 33599076
[TBL] [Abstract][Full Text] [Related]
4. Racial disparities in Black men with prostate cancer: A literature review.
Lillard JW; Moses KA; Mahal BA; George DJ
Cancer; 2022 Nov; 128(21):3787-3795. PubMed ID: 36066378
[TBL] [Abstract][Full Text] [Related]
5. Trends in the Incidence of Fatal Prostate Cancer in the United States by Race.
Kelly SP; Rosenberg PS; Anderson WF; Andreotti G; Younes N; Cleary SD; Cook MB
Eur Urol; 2017 Feb; 71(2):195-201. PubMed ID: 27476048
[TBL] [Abstract][Full Text] [Related]
6. Age-related racial disparities in prostate cancer patients: A systematic review.
He T; Mullins CD
Ethn Health; 2017 Apr; 22(2):184-195. PubMed ID: 27706949
[TBL] [Abstract][Full Text] [Related]
7. Access and Representation: A Narrative Review of the Disparities in Access to Clinical Trials and Precision Oncology in Black men with Prostate Cancer.
Esdaille AR; Ibilibor C; Holmes A; Palmer NR; Murphy AB
Urology; 2022 May; 163():90-98. PubMed ID: 34582887
[TBL] [Abstract][Full Text] [Related]
8. Racial Disparities in Active Surveillance for Prostate Cancer.
Krishna S; Fan Y; Jarosek S; Adejoro O; Chamie K; Konety B
J Urol; 2017 Feb; 197(2):342-349. PubMed ID: 27596691
[TBL] [Abstract][Full Text] [Related]
9. Prostate Cancer Racial Disparities: A Systematic Review by the Prostate Cancer Foundation Panel.
Mahal BA; Gerke T; Awasthi S; Soule HR; Simons JW; Miyahira A; Halabi S; George D; Platz EA; Mucci L; Yamoah K
Eur Urol Oncol; 2022 Feb; 5(1):18-29. PubMed ID: 34446369
[TBL] [Abstract][Full Text] [Related]
10. Trends in mortality among Black and White men with prostate cancer in Massachusetts and Pennsylvania: Race and neighborhood socioeconomic position.
Iyer HS; Gomez SL; Chen JT; Trinh QD; Rebbeck TR
Cancer; 2021 Jul; 127(14):2525-2534. PubMed ID: 33798264
[TBL] [Abstract][Full Text] [Related]
11. Racial differences in trust and regular source of patient care and the implications for prostate cancer screening use.
Carpenter WR; Godley PA; Clark JA; Talcott JA; Finnegan T; Mishel M; Bensen J; Rayford W; Su LJ; Fontham ET; Mohler JL
Cancer; 2009 Nov; 115(21):5048-59. PubMed ID: 19637357
[TBL] [Abstract][Full Text] [Related]
12. Removal of the financial barrier to health care: does it impact on prostate cancer at presentation and survival? A comparative study between black and white men in a Veterans Affairs system.
Powell IJ; Schwartz K; Hussain M
Urology; 1995 Dec; 46(6):825-30. PubMed ID: 7502424
[TBL] [Abstract][Full Text] [Related]
13. The Effect of Other-cause Mortality Adjustment on Access to Alternative Treatment Modalities for Localized Prostate Cancer Among African American Patients.
Bandini M; Preisser F; Nazzani S; Marchioni M; Tian Z; Mazzone E; Graefen M; Montorsi F; Shariat SF; Saad F; Briganti A; Karakiewicz PI
Eur Urol Oncol; 2018 Aug; 1(3):215-222. PubMed ID: 31102624
[TBL] [Abstract][Full Text] [Related]
14. Race-associated expression of MHC class I polypeptide-related sequence A (MICA) in prostate cancer.
Sakiyama MJ; Espinoza I; Reddy A; de Carlo F; Kumar A; Levenson AS; Bae S; Zhou X; Claudio PP; Lewin J; Manucha V; Pound CR; Vijayakumar S; Gomez CR
Exp Mol Pathol; 2019 Jun; 108():173-182. PubMed ID: 31004600
[TBL] [Abstract][Full Text] [Related]
15. Quality of Life Among Black Prostate Cancer Survivors: An Integrative Review.
Dickey SL; Ogunsanya ME
Am J Mens Health; 2018 Sep; 12(5):1648-1664. PubMed ID: 29926761
[TBL] [Abstract][Full Text] [Related]
16. Disparities in uterine cancer epidemiology, treatment, and survival among African Americans in the United States.
Long B; Liu FW; Bristow RE
Gynecol Oncol; 2013 Sep; 130(3):652-9. PubMed ID: 23707671
[TBL] [Abstract][Full Text] [Related]
17. African American Participation in Oncology Clinical Trials--Focus on Prostate Cancer: Implications, Barriers, and Potential Solutions.
Ahaghotu C; Tyler R; Sartor O
Clin Genitourin Cancer; 2016 Apr; 14(2):105-16. PubMed ID: 26786562
[TBL] [Abstract][Full Text] [Related]
18. Racial Differences in the Diagnosis and Treatment of Prostate Cancer.
Pietro GD; Chornokur G; Kumar NB; Davis C; Park JY
Int Neurourol J; 2016 Nov; 20(Suppl 2):S112-119. PubMed ID: 27915474
[TBL] [Abstract][Full Text] [Related]
19. Use of empiric methods to inform prostate cancer health disparities: Comparison of neighborhood-wide association study "hits" in black and white men.
Lynch SM; Sorice K; Tagai EK; Handorf EA
Cancer; 2020 Jan; 126(9):1949-1957. PubMed ID: 32012234
[TBL] [Abstract][Full Text] [Related]
20. Getting back to equal: The influence of insurance status on racial disparities in the treatment of African American men with high-risk prostate cancer.
Mahal BA; Ziehr DR; Aizer AA; Hyatt AS; Sammon JD; Schmid M; Choueiri TK; Hu JC; Sweeney CJ; Beard CJ; D'Amico AV; Martin NE; Lathan C; Kim SP; Trinh QD; Nguyen PL
Urol Oncol; 2014 Nov; 32(8):1285-91. PubMed ID: 24846344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
